BRIEF-AstraZeneca to sell cancer medicine Caprelsa to Genzyme By: Reuters: Company News July 27, 2015 at 02:13 AM EDT * Entered into a definitive agreement with genzyme to divest Caprelsa (vandetanib), a rare disease medicine. Read More >> Related Stocks: Astrazeneca Plc ADR Banco Santander ADR